Owlet, Inc.
NYSE:OWLTMedical - Devices
Healthcare
$3.23 +9.76%
+$0.46 today
- Market cap
- $96.54M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
52W Low $4.19High $16.94
Volume 0.20M
Average 0.24M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$10.80M
FY 2025 · Annual
Investing Cash Flow
-$943,000.00
FY 2025 · Annual
Financing Cash Flow
$32.10M
FY 2025 · Annual
+100.1% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (71.7M) | (79.34M) | (32.9M) | (12.54M) | (38.46M) |
| Depreciation & Amortization | 1.13M | 2.67M | 2.21M | 1.38M | 590K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 4.26M | 12.86M | 9.93M | 8.63M | 9.35M |
| Change in Working Capital | 9.45M | (15.2M) | (4.82M) | (2.52M) | (10.71M) |
| Accounts Receivables | (144K) | (8.5M) | 965K | 2.03M | (10.97M) |
| Inventory | (11.65M) | (1.18M) | 12.12M | (4.14M) | (4.93M) |
| Accounts Payables | 32.12M | (10.72M) | (19.5M) | 1.32M | 5.43M |
| Other Working Capital | (10.87M) | 5.2M | 1.6M | (1.74M) | (236K) |
| Other Non-Cash Items | 16.3M | (2.37M) | 2.05M | (6.16M) | 28.43M |
| Operating Cash Flow | (40.56M) | (81.38M) | (23.53M) | (11.21M) | (10.8M) |
| Capital Expenditures | (2.02M) | (1.57M) | (59K) | (761K) | (273K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.05M) | (929K) | (43K) | (726K) | 0 |
| Investing Cash Flow | (2.02M) | (1.57M) | (59K) | (761K) | (943K) |
| Debt Repayment | (3.49M) | (1.5M) | 156K | (816K) | 55K |
| Common Stock Issued | 0 | 0 | 0 | 10M | 34.69M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 124.11M | 618K | 269K | (2M) | (2.64M) |
| Financing Cash Flow | 120.62M | (878K) | 28.91M | 16.04M | 32.1M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 78.05M | (83.82M) | 5.33M | 4.07M | 20.38M |
| Free Cash Flow | (42.58M) | (82.95M) | (23.59M) | (11.97M) | (11.07M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$38.5M
+ D&A$590.0K
+ Stock-Based Comp$9.3M
+ Deferred Tax$0
- Working Capital-$10.7M
+ Other Non-Cash$28.4M
= Operating Cash Flow-$10.8M
- Capex-$273.0K
= Free Cash Flow-$11.1M
Analysis
FY2025 free cash flow is -$11.1M. FCF conversion is 28.8% of net income. Operating cash flow was -$10.8M, with capex of -$273.0K. The largest bridge item is Other Non-Cash at $28.4M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 8, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 21, 2026 |
Does OWLT generate free cash flow?
Owlet, Inc. (OWLT) generated -$11.06M of free cash flow in fiscal 2025.
How much operating cash flow does OWLT produce?
Operating cash flow was -$10.80M, before capital expenditures of $273,000.00.
Continue the stock analysis
Jump to another research area for this company.